NO176004C - Fremgangsmåte ved fremstilling av vaksine mot hunde-coronavirus - Google Patents

Fremgangsmåte ved fremstilling av vaksine mot hunde-coronavirus

Info

Publication number
NO176004C
NO176004C NO882500A NO882500A NO176004C NO 176004 C NO176004 C NO 176004C NO 882500 A NO882500 A NO 882500A NO 882500 A NO882500 A NO 882500A NO 176004 C NO176004 C NO 176004C
Authority
NO
Norway
Prior art keywords
canine coronavirus
vaccine against
ccv
against canine
preparing vaccine
Prior art date
Application number
NO882500A
Other languages
English (en)
Other versions
NO176004B (no
NO882500D0 (no
NO882500L (no
Inventor
Michael Alonzo Gill
Stephen Wayne May
Original Assignee
Norden Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Lab Inc filed Critical Norden Lab Inc
Publication of NO882500D0 publication Critical patent/NO882500D0/no
Publication of NO882500L publication Critical patent/NO882500L/no
Publication of NO176004B publication Critical patent/NO176004B/no
Publication of NO176004C publication Critical patent/NO176004C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO882500A 1987-06-08 1988-06-07 Fremgangsmåte ved fremstilling av vaksine mot hunde-coronavirus NO176004C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,437 US4904468A (en) 1987-06-08 1987-06-08 Canine coronavirus vaccine

Publications (4)

Publication Number Publication Date
NO882500D0 NO882500D0 (no) 1988-06-07
NO882500L NO882500L (no) 1988-12-09
NO176004B NO176004B (no) 1994-10-10
NO176004C true NO176004C (no) 1995-01-18

Family

ID=22022943

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882500A NO176004C (no) 1987-06-08 1988-06-07 Fremgangsmåte ved fremstilling av vaksine mot hunde-coronavirus

Country Status (20)

Country Link
US (1) US4904468A (no)
EP (1) EP0295057B1 (no)
JP (1) JP2655876B2 (no)
KR (1) KR970000233B1 (no)
AT (1) ATE91902T1 (no)
AU (1) AU612151B2 (no)
CA (1) CA1337267C (no)
DE (1) DE3882599T2 (no)
DK (1) DK175410B1 (no)
ES (1) ES2058283T3 (no)
FI (1) FI87531C (no)
HU (1) HU203984B (no)
IE (1) IE63006B1 (no)
IL (1) IL86635A0 (no)
MY (1) MY103575A (no)
NO (1) NO176004C (no)
NZ (1) NZ224865A (no)
PH (1) PH27018A (no)
PT (1) PT87668B (no)
ZA (1) ZA884040B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
US5232694A (en) * 1989-05-03 1993-08-03 Akzo N.V. Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US5643577A (en) * 1990-04-24 1997-07-01 The University Of Newcastle Research Associates Limited Oral vaccine comprising antigen surface-associated with red blood cells
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
DK0510773T3 (da) * 1991-04-25 2004-04-19 Akzo Nobel Nv Canine coronavirus subunit-vaccine
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
ES2182827T3 (es) * 1992-05-08 2003-03-16 Pfizer Gen del virus corona canino y usos del mismo.
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
ATE493430T1 (de) * 2005-10-26 2011-01-15 Canio Buonavoglia Pantropisches hundecoronavirus
US7761389B2 (en) 2007-08-23 2010-07-20 Gm Global Technology Operations, Inc. Method for anomaly prediction of battery parasitic load
BR112012008861A2 (pt) * 2009-10-14 2019-09-24 Univ Oklahoma State parvovírus, vacina, ácido nucleico isolado, composição imunogênica, método para provocar uma resposta imune em um animal contra a infecção por parvovírus, proteína vp-2 de parvovírus purificada, vetor de expressão, e método para exterminar células tumorais em um mamífero.
WO2014080676A1 (ja) 2012-11-22 2014-05-30 旭化成メディカル株式会社 高感染価のパルボウイルスの生産方法
CN106290880B (zh) * 2015-05-27 2019-01-04 江苏雷森生物科技有限公司 一种用于犬冠状病毒的免疫层析用试剂组合物及检测方法
KR102036467B1 (ko) 2015-11-06 2019-10-24 아사히 가세이 메디컬 가부시키가이샤 고감염가 또한 고순도의 파보바이러스의 생산 방법
CN110903387A (zh) * 2019-12-17 2020-03-24 吉林省纽卓莱生物科技有限责任公司 一种犬冠状病毒免疫球蛋白F(ab′)2及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
WO1986005806A1 (en) * 1985-03-29 1986-10-09 National Research Development Corporation Infectious bronchitis virus spike protein

Also Published As

Publication number Publication date
DK301588D0 (da) 1988-06-02
DK175410B1 (da) 2004-09-27
NO176004B (no) 1994-10-10
ES2058283T3 (es) 1994-11-01
CA1337267C (en) 1995-10-10
NZ224865A (en) 1990-12-21
DE3882599T2 (de) 1994-02-10
ZA884040B (en) 1989-09-27
AU1747688A (en) 1988-12-08
EP0295057A2 (en) 1988-12-14
NO882500D0 (no) 1988-06-07
IE881689L (en) 1988-12-08
FI87531B (fi) 1992-10-15
FI882689A (fi) 1988-12-09
IL86635A0 (en) 1988-11-30
KR890000105A (ko) 1989-03-11
JPS63316739A (ja) 1988-12-26
MY103575A (en) 1993-08-28
HUT46858A (en) 1988-12-28
EP0295057A3 (en) 1989-12-27
AU612151B2 (en) 1991-07-04
PT87668A (pt) 1988-07-01
PH27018A (en) 1993-02-01
NO882500L (no) 1988-12-09
DE3882599D1 (de) 1993-09-02
FI882689A0 (fi) 1988-06-07
US4904468A (en) 1990-02-27
PT87668B (pt) 1992-09-30
EP0295057B1 (en) 1993-07-28
JP2655876B2 (ja) 1997-09-24
FI87531C (fi) 1993-01-25
KR970000233B1 (ko) 1997-01-08
ATE91902T1 (de) 1993-08-15
DK301588A (da) 1988-12-09
IE63006B1 (en) 1995-03-22
HU203984B (en) 1991-11-28

Similar Documents

Publication Publication Date Title
NO176004C (no) Fremgangsmåte ved fremstilling av vaksine mot hunde-coronavirus
PT88178A (pt) Metodo para a purificacao de virus da hepatite a
DE69426051D1 (de) Infektiösen Bronchitis Virus 4/91 enthaltender Geflügel-Impfstoff
DK0465204T3 (da) Vaccine mod Lyme sygdom
HK1005541A1 (en) Treatment of helicobacter associated gastroduodenal disease
NZ195184A (en) Live feline infectious peritonitis (fip) virus vaccine; fip virus atcc no.vr-2004
DE3853672T2 (de) Nichtzurückschlagende RNS-Viren.
DE68920345D1 (de) Lebendes Kombinationsvakzin.
HUT47867A (en) Process for producing vaccine against infective peritonitis of cat
EP0485463A4 (en) Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
ES2084587T3 (es) Arn virus no revertientes.

Legal Events

Date Code Title Description
MK1K Patent expired